Physician

Shahid M Ansari, MD

According to 2025 Medicare claims, Shahid Ansari, MD (NPI: 1376518175) practices internal medicine in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is RESIDENTIAL VISITING PHYSICIAN SERVICES PLLC. (NPI: 1134637275) and primary practice location at 48152-3093. Ansari is affiliated with the CCA ACO LLC (ACO ID: A2198), participating under the MSSP model.

Ansari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 182 traditional Medicare patients, billed 757 HCPCS/CPT codes, and received $47,515 in Medicare payments. The top billing code was 99349 (Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes). Part D data shows 5,221 prescription claims across 596 beneficiaries totaling $445,856 in drug costs, led by Jardiance (Empagliflozin). 2023 DME data shows 11 claims. Open Payments data shows 5 records totaling $97. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $207,734 to $47,515. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $11,561 and ending at $424.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$166K$332K2015 Medicare payment: $207,734 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $156,422 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $170,123 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $306,184 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $331,502 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $168,292 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $143,156 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $124,874 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $100,085 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $47,515 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152124,043$207,734
20161513,075$156,422
20171993,336$170,123
20183924,621$306,184
20194494,990$331,502
20202792,467$168,292
20213841,968$143,156
20224361,790$124,874
20233201,488$100,085
2024182757$47,515

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$409K$819K2015 Drug cost: $550,905 (USD; Tot_Drug_Cst)2016 Drug cost: $585,053 (USD; Tot_Drug_Cst)2017 Drug cost: $570,945 (USD; Tot_Drug_Cst)2018 Drug cost: $743,979 (USD; Tot_Drug_Cst)2019 Drug cost: $818,608 (USD; Tot_Drug_Cst)2020 Drug cost: $551,127 (USD; Tot_Drug_Cst)2021 Drug cost: $393,404 (USD; Tot_Drug_Cst)2022 Drug cost: $390,231 (USD; Tot_Drug_Cst)2023 Drug cost: $346,694 (USD; Tot_Drug_Cst)2024 Drug cost: $445,856 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201529611,004$550,905
201626111,413$585,053
201727610,101$570,945
201836912,087$743,979
201945312,793$818,608
20202938,313$551,127
20214036,192$393,404
20225194,930$390,231
20235143,989$346,694
20245965,221$445,856

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$13K$26K2015 Medicare payment: $25,514 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $8,480 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $11,344 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $6,629 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $13,682 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $9,051 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $9,212 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $6,515 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $482 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R422$25,514
2016N/R124$8,480
2017N/R161$11,344
2018N/R233$6,629
201929223$13,682
2020N/R210$9,051
2021N/R183$9,212
2022N/R54$6,515
2023N/R11$482
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99349Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes17110$102
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more126216$86
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5776$59
99490Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month22118$50
96372Injection of drug or substance under skin or into muscle3145$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JardianceEmpagliflozin863,300$63,437
JanuviaSitagliptin Phosphate512,430$43,742
EliquisApixaban472,019$38,828
OzempicSemaglutide23982$29,936
LinzessLinaclotide351,350$22,959

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$97Boston Scientific Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Shahid M. Ansari, MD?

Tedicare shows public-source Medicare data for Shahid M. Ansari, MD (NPI 1376518175), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shahid M. Ansari, MD have ACO affiliation data?

Shahid M. Ansari, MD is shown with ACO affiliation data for CCA ACO LLC (MSSP, ACO ID A2198).

What billing organization is linked to Shahid M. Ansari, MD?

Shahid M. Ansari, MD is linked to RESIDENTIAL VISITING PHYSICIAN SERVICES PLLC. (billing NPI 1134637275) in the available physician profile data.

Does Shahid M. Ansari, MD have Open Payments data?

Shahid M. Ansari, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.